These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8677515)
1. Tamoxifen--breast cancer preventive or human carcinogen? Clute E Toxicol Ind Health; 1995; 11(5):503-10. PubMed ID: 8677515 [TBL] [Abstract][Full Text] [Related]
2. The tamoxifen controversy--clinical chemopreventive agent and experimental carcinogen. Pitot HC Proc Soc Exp Biol Med; 1995 Feb; 208(2):139-40. PubMed ID: 7831344 [No Abstract] [Full Text] [Related]
3. First do no harm: extending the debate on the provision of preventive tamoxifen. Will BP; Nobrega KM; Berthelot JM; Flanagan W; Wolfson MC; Logan DM; Evans WK Br J Cancer; 2001 Nov; 85(9):1280-8. PubMed ID: 11720461 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen to prevent breast cancer. Morrow M; Jordan VC Adv Surg; 2000; 34():287-99. PubMed ID: 10997224 [No Abstract] [Full Text] [Related]
5. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen for the prevention of breast cancer: yes. Vogel VG; Saenz M Important Adv Oncol; 1995; ():187-200. PubMed ID: 7672805 [No Abstract] [Full Text] [Related]
10. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen. Dal Cin P; Timmerman D; Van den Berghe I; Wanschura S; Kazmierczak B; Vergote I; Deprest J; Neven P; Moerman P; Bullerdiek J; Van den Berghe H Cancer Res; 1998 Jun; 58(11):2278-81. PubMed ID: 9622058 [TBL] [Abstract][Full Text] [Related]
11. Confusion reigns over breast cancer. Birmingham K Nat Med; 2001 Dec; 7(12):1266. PubMed ID: 11726953 [No Abstract] [Full Text] [Related]
12. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Jordan VC Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908 [No Abstract] [Full Text] [Related]
13. Tamoxifen and breast cancer prevention: what should you tell your patients? Goel V CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176 [No Abstract] [Full Text] [Related]
14. Tamoxifen for the prevention of breast cancer: no. DeGregorio MW; Maenpaa JU; Wiebe VJ Important Adv Oncol; 1995; ():175-85. PubMed ID: 7672804 [TBL] [Abstract][Full Text] [Related]
15. Restricted entry to the tamoxifen trial. Rees DA BMJ; 1992 Mar; 304(6830):844. PubMed ID: 1392733 [No Abstract] [Full Text] [Related]
16. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint. Fabian C Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909 [No Abstract] [Full Text] [Related]
17. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. Jordan VC Annu Rev Pharmacol Toxicol; 1995; 35():195-211. PubMed ID: 7598491 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and breast cancer--from palliation to prevention. Rich SE Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194 [TBL] [Abstract][Full Text] [Related]
19. Overview of the main outcomes in breast-cancer prevention trials. Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863 [TBL] [Abstract][Full Text] [Related]
20. Risk factors and the prevention of breast cancer with tamoxifen. Morrow M; Jordan VC Cancer Surv; 1993; 18():211-29. PubMed ID: 8012998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]